Literature DB >> 16978875

A genome wide analysis of ubiquitin ligases in APP processing identifies a novel regulator of BACE1 mRNA levels.

Amy S Espeseth1, Qian Huang, Adam Gates, Min Xu, Yuanjiang Yu, Adam J Simon, Xiao-Ping Shi, Xiaohua Zhang, Paul Hodor, David J Stone, Julja Burchard, Guy Cavet, Steven Bartz, Peter Linsley, William J Ray, Daria Hazuda.   

Abstract

Proteolysis of beta-amyloid precursor protein (APP) into amyloid beta peptide (Abeta) by beta- and gamma-secretases is a critical step in the pathogenesis of Alzheimer's Disease (AD), but the pathways regulating secretases are not fully characterized. Ubiquitinylation, which is dysregulated in AD, may affect APP processing. Here, we describe a screen for APP processing modulators using an siRNA library targeting 532 predicted ubiquitin ligases. Seven siRNA pools diminished Abeta production. Of these, siRNAs targeting PPIL2 (hCyp-60) suppressed beta-site cleavage. Knockdown of PPIL2 mRNA decreased BACE1 mRNA, while overexpression of PPIL2 cDNA enhanced BACE1 mRNA levels. Microarray analysis of PPIL2 or BACE1 knockdown indicated that genes affected by BACE1 knockdown are a subset of those dependent upon PPIL2; suggesting that BACE1 expression is downstream of PPIL2. The association of PPIL2 with BACE expression and its requirement for Abeta production suggests new approaches to discover disease modifying agents for AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16978875     DOI: 10.1016/j.mcn.2006.07.003

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  8 in total

1.  Variation in RTN3 and PPIL2 genes does not influence platelet membrane beta-secretase activity or susceptibility to alzheimer's disease in the northern Irish population.

Authors:  Robyn Carson; Amy Jayne McKnight; Stephen Todd; Wei Wei Liu; Shirley Heggarty; David Craig; Bernadette McGuinness; G Brent Irvine; A Peter Passmore; Janet A Johnston
Journal:  Neuromolecular Med       Date:  2009       Impact factor: 3.843

Review 2.  The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease.

Authors:  Laura J Blair; Jeremy D Baker; Jonathan J Sabbagh; Chad A Dickey
Journal:  J Neurochem       Date:  2015-02-24       Impact factor: 5.372

3.  Defining a standard and weighted mathematical index for maturation of dendritic cells.

Authors:  Abdolamir Landi; Mohammad Tayfeh Aligodarzi; Ali Khodadadi; Lorne A Babiuk; Sylvia van Drunen Littel-van den Hurk
Journal:  Immunology       Date:  2017-11-24       Impact factor: 7.397

4.  Viable mouse gene ablations that robustly alter brain Aβ levels are rare.

Authors:  Jeremy H Toyn; Xu-Alan Lin; Mark W Thompson; Valerie Guss; Jere E Meredith; Sethu Sankaranarayanan; Nestor Barrezueta; John Corradi; Antara Majumdar; Daniel L Small; Melissa Hansard; Thomas Lanthorn; Ryan S Westphal; Charles F Albright
Journal:  BMC Neurosci       Date:  2010-11-05       Impact factor: 3.288

5.  Ancient origin of animal U-box ubiquitin ligases.

Authors:  Ignacio Marín
Journal:  BMC Evol Biol       Date:  2010-10-27       Impact factor: 3.260

6.  Genome-wide screens for effective siRNAs through assessing the size of siRNA effects.

Authors:  Xiaohua Douglas Zhang
Journal:  BMC Res Notes       Date:  2008-06-23

Review 7.  Roles of Prolyl Isomerases in RNA-Mediated Gene Expression.

Authors:  Roopa Thapar
Journal:  Biomolecules       Date:  2015-05-18

8.  Hit selection with false discovery rate control in genome-scale RNAi screens.

Authors:  Xiaohua Douglas Zhang; Pei Fen Kuan; Marc Ferrer; Xiaohua Shu; Yingxue C Liu; Adam T Gates; Priya Kunapuli; Erica M Stec; Min Xu; Shane D Marine; Daniel J Holder; Berta Strulovici; Joseph F Heyse; Amy S Espeseth
Journal:  Nucleic Acids Res       Date:  2008-07-15       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.